Literature DB >> 23018864

HOX and TALE signatures specify human stromal stem cell populations from different sources.

Jacopo Picchi1, Luisa Trombi, Laura Spugnesi, Serena Barachini, Giorgia Maroni, Giovanni Barbanti Brodano, Stefano Boriani, Mauro Valtieri, Mario Petrini, Maria Cristina Magli.   

Abstract

Human stromal stem cell populations reside in different tissues and anatomical sites, however a critical question related to their efficient use in regenerative medicine is whether they exhibit equivalent biological properties. Here, we compared cellular and molecular characteristics of stromal stem cells derived from the bone marrow, at different body sites (iliac crest, sternum, and vertebrae) and other tissues (dental pulp and colon). In particular, we investigated whether homeobox genes of the HOX and TALE subfamilies might provide suitable markers to identify distinct stromal cell populations, as HOX proteins control cell positional identity and, together with their co-factors TALE, are involved in orchestrating differentiation of adult tissues. Our results show that stromal populations from different sources, although immunophenotypically similar, display distinct HOX and TALE signatures, as well as different growth and differentiation abilities. Stromal stem cells from different tissues are characterized by specific HOX profiles, differing in the number and type of active genes, as well as in their level of expression. Conversely, bone marrow-derived cell populations can be essentially distinguished for the expression levels of specific HOX members, strongly suggesting that quantitative differences in HOX activity may be crucial. Taken together, our data indicate that the HOX and TALE profiles provide positional, embryological and hierarchical identity of human stromal stem cells. Furthermore, our data suggest that cell populations derived from different body sites may not represent equivalent cell sources for cell-based therapeutical strategies for regeneration and repair of specific tissues.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23018864     DOI: 10.1002/jcp.24239

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  PKNOX2 expression and regulation in the bone marrow mesenchymal stem cells of Fanconi anemia patients and healthy donors.

Authors:  Ilgin Cagnan; Erdal Cosgun; Ozlen Konu; Duygu Uckan; Aysen Gunel-Ozcan
Journal:  Mol Biol Rep       Date:  2018-12-04       Impact factor: 2.316

2.  Comparison of gene expression between mandibular and iliac bone-derived cells.

Authors:  Jung-Tae Lee; So-Young Choi; Hyung-Lak Kim; Jae-Young Kim; Heon-Jin Lee; Tae-Geon Kwon
Journal:  Clin Oral Investig       Date:  2014-11-05       Impact factor: 3.573

3.  Mesenchymal stem cells derived from vertebrae (vMSCs) show best biological properties.

Authors:  Giovanni Barbanti Brodano; Silvia Terzi; Luisa Trombi; Cristiana Griffoni; Mauro Valtieri; Stefano Boriani; Maria Cristina Magli
Journal:  Eur Spine J       Date:  2013-09-24       Impact factor: 3.134

4.  The relationship among HOXA10, estrogen receptor α, progesterone receptor, and progesterone receptor B proteins in rectosigmoid endometriosis: a tissue microarray study.

Authors:  Alysson Zanatta; Ricardo Mendes Alves Pereira; André Monteiro da Rocha; Bruno Cogliati; Edmund Chada Baracat; Hugh S Taylor; Eduardo Leme Alves da Motta; Paulo Cesar Serafini
Journal:  Reprod Sci       Date:  2014-09-11       Impact factor: 3.060

5.  The angiogenic variation of skeletal site-specific human BMSCs from same alveolar cleft patients: a comparative study.

Authors:  Yifei Du; Fei Jiang; Yi Liang; Yuli Wang; Weina Zhou; Yongchu Pan; Mingfei Xue; Yan Peng; Huan Yuan; Ning Chen; Hongbing Jiang
Journal:  J Mol Histol       Date:  2016-02-04       Impact factor: 2.611

6.  Mesenchymal stem cells from sternum: the type of heart disease, ischemic or valvular, does not influence the cell culture establishment and growth kinetics.

Authors:  Lucinara Dadda Dias; Karina Rabello Casali; Carine Ghem; Melissa Kristocheck da Silva; Grasiele Sausen; Patrícia Bonini Palma; Dimas Tadeu Covas; Renato A K Kalil; Beatriz D Schaan; Nance Beyer Nardi; Melissa Medeiros Markoski
Journal:  J Transl Med       Date:  2017-07-25       Impact factor: 5.531

7.  Combined Analysis of Endothelial, Hematopoietic, and Mesenchymal Stem Cell Compartments Shows Simultaneous but Independent Effects of Age and Heart Disease.

Authors:  Carine Ghem; Lucinara Dadda Dias; Roberto Tofani Sant'Anna; Renato A K Kalil; Melissa Markoski; Nance Beyer Nardi
Journal:  Stem Cells Int       Date:  2017-07-27       Impact factor: 5.443

Review 8.  Mesenchymal Stem Cells for the Treatment of Spinal Arthrodesis: From Preclinical Research to Clinical Scenario.

Authors:  F Salamanna; M Sartori; G Barbanti Brodano; C Griffoni; L Martini; S Boriani; M Fini
Journal:  Stem Cells Int       Date:  2017-02-13       Impact factor: 5.443

Review 9.  Gut Mesenchymal Stromal Cells in Immunity.

Authors:  Valeria Messina; Carla Buccione; Giulia Marotta; Giovanna Ziccheddu; Michele Signore; Gianfranco Mattia; Rossella Puglisi; Benedetto Sacchetti; Livia Biancone; Mauro Valtieri
Journal:  Stem Cells Int       Date:  2017-02-28       Impact factor: 5.443

10.  The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC).

Authors:  F Hakami; L Darda; P Stafford; P Woll; D W Lambert; K D Hunter
Journal:  Br J Cancer       Date:  2014-07-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.